...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Questrade

Yes, I have, but smaller orders. It may be ok now, but no takers at .15

Share
New Message
Please login to post a reply